CHOICE OF ANTIHYPERTENSIVE THERAPY IN PREGNANT WOMEN: ANALYSIS OF CURRENT GUIDELINES
The purpose of the work – to carry out an analysis of modern international guidelines forthe treatment of arterial hypertension in pregnant women.Conclusions. According to the most recommendations, labetalol, nifedipine, andmethyldopa in solid dosage form are the drugs of the first line of therapy. Labetalol(intravenous), hydralazine (intravenous or intramuscular) and immediate- releasenifedipine are used in emergency settings. For the purpose of pharmacocorrection ofpreeclampsia, the appointment of acetylsalicylic acid is relevant, the dose range of thedrug ranges from 75 to 162 mg/day before bedtime.
Authors
- Yu. S. Bukataru
- О. В. Геруш (ORCID: https://orcid.org/0000-0001-9100-0070)
- А. В. Кононенко (ORCID: https://orcid.org/0000-0003-0845-9353)
- E. V. Bondarev
- К. О. Каlko
- I. Labibi
- M.V. Savohina
Institutions
- National University Odesa Law Academy (UA)
- Bukovinian State Medical University (UA)
- National University of Pharmacy (UA)
Publication Details
- Journal
- Clinical & experimental pathology
- Published
- 2024-12-12
- DOI
- https://doi.org/10.24061/1727-4338.xxiii.3.89.2024.06
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00